Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer.
| Autor: | Johnston S, Pippen J Jr, Pivot X, Lichinitser M, Sadeghi S, Dieras V, Gomez HL, Romieu G, Manikhas A, Kennedy MJ, Press MF, Maltzman J, Florance A, O'Rourke L, Oliva C, Stein S, Pegram M |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 11/20/2009, Vol. 27 Issue 33, p5538-5546, 9p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|